Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

293
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
293
Positron Emission Tomography01:29

Positron Emission Tomography

6.4K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

73
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
73
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.9K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced Regional Brain Metabolism in Stroke-Free Atrial Fibrillation Patients: Insights From a Pilot FDG-PET Study.

JACC. Clinical electrophysiology·2026
Same author

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria.

Alzheimer's & dementia (Amsterdam, Netherlands)·2025
Same author

Impact of Computed Tomography-Derived Body Composition Analysis on the Performance of GFR Estimating Equations in Patients with Cancer.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Neuroinflammation and amyloid load in different age groups of individuals with Down syndrome: A PET imaging study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Corrigendum to "Accuracy of CT colonography with mannitol preparation for detecting synchronous lesions in obstructive colorectal cancer" [Eur. J. Radiol. 188 (2025) 112151].

European journal of radiology·2025
Same author

Accuracy of CT colonography with mannitol preparation for detecting synchronous lesions in obstructive colorectal cancer.

European journal of radiology·2025

Related Experiment Video

Updated: Nov 4, 2025

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.2K

General Concepts in Theranostics.

Rafael F Nunes1, Roberta M F Zuppani2, Artur M Coutinho3

  • 1Department of Radiology, Hospital Sirio-Libanes, Sao Paulo, Brazil.

PET Clinics
|May 31, 2021
PubMed
Summary

Theranostics combines diagnostic imaging and targeted therapy, with nuclear medicine leading the way. This approach personalizes disease management for improved patient outcomes and treatment precision.

Keywords:
DiagnosisMolecular imagingNuclear medicineTheranosticsTherapy

More Related Videos

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

1.6K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

621

Related Experiment Videos

Last Updated: Nov 4, 2025

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.2K
Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

1.6K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

621

Area of Science:

  • Nuclear medicine
  • Molecular imaging
  • Targeted radionuclide therapy

Background:

  • Theranostics integrates diagnostic and therapeutic applications targeting specific molecules.
  • Nuclear medicine is central to theranostics, utilizing radioactive tracers for both imaging and therapy.
  • The rise of personalized medicine fuels the importance of theranostic strategies.

Purpose of the Study:

  • To provide a comprehensive overview of theranostics in nuclear medicine.
  • To discuss the fundamental concepts, background, and features of theranostic approaches.
  • To explore the future directions of theranostics in medical imaging and therapy.

Main Methods:

  • Review of general concepts in theranostics.
  • Discussion of nuclear medicine's role in theranostic applications.
  • Analysis of current and future trends in theranostic imaging and therapy.

Main Results:

  • Theranostics enables customized disease management.
  • Improved patient selection and response prediction are key benefits.
  • Reduced toxicity and enhanced prognostic estimation are achieved.

Conclusions:

  • Theranostics represents a significant advancement in personalized medicine.
  • Nuclear medicine is pivotal in advancing theranostic capabilities.
  • The integration of diagnostics and therapeutics offers a promising future for targeted treatments.